Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
The Ras Gene02:38

The Ras Gene

6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miR-1-3p downregulation drives tumor invasion in oral squamous cell carcinoma: insights from in vitro, in vivo, and ex vivo models.

Molecular biology reports·2026
Same author

Metabolic insights into male fertility: a narrative review of the role of adiponectin on the hypothalamic-pituitary-testicular axis†.

Biology of reproduction·2025
Same author

Zebrafish as a Model for Translational Immuno-Oncology.

Journal of personalized medicine·2025
Same author

Chemotherapy-induced neuropathy in monomethyl Auristatin E treatment: prevention by lithium.

British journal of cancer·2025
Same author

Extracellular Signaling Molecules from Adipose-Derived Stem Cells and Ovarian Cancer Cells Induce a Hybrid Epithelial-Mesenchymal Phenotype in a Bidirectional Interaction.

Cells·2025
Same author

Efficacy and tolerability of 1.6% phenol-croton peeling vs. topical 5% imiquimod in the treatment of actinic cheilitis: a randomized controlled trial.

Clinical and experimental dermatology·2024

Related Experiment Video

Updated: Jun 16, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.8K

SLIT/ROBO Pathway and Prostate Cancer: Gene and Protein Expression and Their Prognostic Values.

Nilton J Santos1,2, Francielle C Mosele1, Caroline N Barquilha1,2

  • 1Laboratory of Extracellular Matrix Biology, Department of Structural and Functional Biology, Institute of Biosciences of Botucatu (IBB), São Paulo State University (UNESP), Botucatu 18618-689, São Paulo, Brazil.

International Journal of Molecular Sciences
|June 13, 2025
PubMed
Summary
This summary is machine-generated.

Researchers identified the SLIT/ROBO pathway as a potential biomarker for prostate cancer (PCa) prognosis. This discovery offers new therapeutic targets for improving patient outcomes in PCa.

Keywords:
PtenRNA-seqROBOSLITextracellular matrixknockout micep53prostate cancer

More Related Videos

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

13.4K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.8K

Related Experiment Videos

Last Updated: Jun 16, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.8K
Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

13.4K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.8K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Prostate cancer (PCa) is a leading cause of cancer mortality in men, necessitating improved prognostic markers.
  • Tumor microenvironment components, including cell surface glycoproteins, influence PCa progression and metastasis.
  • Current markers lack the precision needed for effective patient risk stratification.

Purpose of the Study:

  • To investigate the expression and localization of the SLIT/ROBO pathway in prostate cancer.
  • To identify novel prognostic markers and potential therapeutic targets for PCa.
  • To correlate SLIT/ROBO pathway alterations with patient prognosis and tumor characteristics.

Main Methods:

  • Histopathological and immunohistochemical analyses of PCa in knockout mouse models and human samples.
  • Bioinformatic and transcriptomic analyses to assess gene expression changes.
  • Validation using public datasets (The Human Protein Atlas, cBioPortal, SurvExpress, CamcAPP) correlating gene/protein expression with clinical data.

Main Results:

  • Transcriptomic analysis revealed significant alterations in SLIT/ROBO pathway gene expression in PCa.
  • Gene and protein expression of SLIT1, SLIT2, ROBO1, and ROBO4 were characterized in mouse models and human tumors.
  • Expression levels of SLIT/ROBO pathway components correlated with Gleason scores and patient prognosis.

Conclusions:

  • The SLIT/ROBO pathway components (SLIT1, SLIT2, ROBO1, ROBO4) show potential as prognostic and predictive biomarkers for PCa.
  • The SLIT/ROBO pathway represents a promising target for novel therapeutic strategies in prostate cancer treatment.